Metopirone
Payments companies reported to CMS as associated with Metopirone. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Metopirone, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Metopirone
These are the largest totals companies reported as associated with Metopirone. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Eliza Geer | New York, NY | Endocrinology, Diabetes & Metabolism | $1,770.00 |
| Meeta Bhalla | Bellaire, TX | Internal Medicine | $155.73 |
| Alexander Navolanic | Cleveland, OH | Physician Assistant | $145.00 |
| Rebecca Thompson | Cleveland, OH | Family | $145.00 |
| H Beyer | Fort Wayne, IN | Endocrinology, Diabetes & Metabolism | $124.00 |
| Alice Levine | New York, NY | Endocrinology, Diabetes & Metabolism | $75.25 |
| Irina Bancos | Rochester, MN | Endocrinology, Diabetes & Metabolism | $69.00 |
| Emily Kachelmeyer | Summerville, SC | Gerontology (Clinical Nurse Specialist) | $34.94 |
| Lauren Podoll | Summerville, SC | Physician Assistant | $34.94 |
| Nicholas Trudo | Joint Base Charleston, SC | Physician Assistant | $34.94 |
Prescribed Metopirone?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.